Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eastman, R. C.
Right arrow Articles by Harris, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eastman, R. C.
Right arrow Articles by Harris, M.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 20, Issue 5 735-744, Copyright © 1997 by American Diabetes Association

ARTICLES

Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia

RC Eastman, JC Javitt, WH Herman, EJ Dasbach, C Copley-Merriman, W Maier, F Dong, D Manninen, AS Zbrozek, J Kotsanos, SA Garfield and M Harris
Division of Diabetes, Endocrinology, and Metabolic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892-2560, USA.

OBJECTIVE: To analyze the health benefits and economics of treating NIDDM with the goal of normoglycemia. RESEARCH DESIGN AND METHODS: Incidence-based simulation model of NIDDM was used. Hazard rates for complications were adjusted for glycemia using risk gradients from the Diabetes Control and Complications Trial. Treatment costs were estimated from national survey data and clinical trials. Incremental costs and benefits were expressed in present value dollars (3% discount rate). Life-years were adjusted for quality of life, yielding quality-adjusted life-years (QALYs). RESULTS: Comprehensive treatment of NIDDM that maintains an HbA1c value of 7.2% is predicted to reduce the cumulative incidence of blindness, end-stage renal disease, and lower-extremity amputation by 72, 87, and 67%, respectively. Cardiovascular disease risk increased by 3% (no effect of treating glycemia is assumed). Life expectancy increased 1.39 years. The cost of treating hyperglycemia increased by almost twofold, which is partially offset by reductions in the cost of complications. The estimated incremental cost/QALY gained is $16,002. Treatment is more cost-effective for those with longer glycemic exposure (earlier onset of diabetes), minorities, and those with higher HbA1c under standard care. CONCLUSIONS: The incremental effectiveness of treating NIDDM with the goal of normoglycemia is estimated to be approximately $16,000/QALY gained, which is in the range of interventions that are generally considered cost-effective.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
E. S. Huang, Q. Zhang, N. Gandra, M. H. Chin, and D. O. Meltzer
The Effect of Comorbid Illness and Functional Status on the Expected Benefits of Intensive Glucose Control in Older Patients with Type 2 Diabetes: A Decision Analysis
Ann Intern Med, July 1, 2008; 149(1): 11 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Health Aff (Millwood)Home page
S. Colagiuri and A. E. Walker
Using An Economic Model Of Diabetes To Evaluate Prevention And Care Strategies In Australia
Health Aff., January 1, 2008; 27(1): 256 - 268.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. Bu, E. Pan, J. Walker, J. Adler-Milstein, D. Kendrick, J. M. Hook, C. M. Cusack, D. W. Bates, and B. Middleton
Benefits of Information Technology-Enabled Diabetes Management
Diabetes Care, May 1, 2007; 30(5): 1137 - 1142.
[Abstract] [Full Text] [PDF]

Home page
 Int J Qual Health CareHome page
D. Aron, M. Rajan, and L. M. Pogach
Summary measures of quality of diabetes care: comparison of continuous weighted performance measurement and dichotomous thresholds
Int. J. Qual. Health Care, February 1, 2007; 19(1): 29 - 36.
[Abstract] [Full Text] [PDF]

Home page
 JRSMHome page
A. G Mainous III, V. A Diaz, S. Saxena, R. Baker, C. J Everett, R. J Koopman, and A. Majeed
Diabetes management in the USA and England: comparative analysis of national surveys
J R Soc Med, September 1, 2006; 99(9): 463 - 469.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. R. Rubin, M. Peyrot, L. M. Siminerio, and on behalf of the International DAWN Advisory Panel
Health Care and Patient-Reported Outcomes: Results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study.
Diabetes Care, June 1, 2006; 29(6): 1249 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. M. Pogach, M. Rajan, and D. C. Aron
Comparison of Weighted Performance Measurement and Dichotomous Thresholds for Glycemic Control in the Veterans Health Administration
Diabetes Care, February 1, 2006; 29(2): 241 - 246.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. S. Huang, M. Shook, L. Jin, M. H. Chin, and D. O. Meltzer
The Impact of Patient Preferences on the Cost-Effectiveness of Intensive Glucose Control in Older Patients With New-Onset Diabetes
Diabetes Care, February 1, 2006; 29(2): 259 - 264.
[Abstract] [Full Text] [PDF]

Home page
 American Journal of Medical QualityHome page
P. Hollander, D. Nicewander, C. Couch, D. Winter, J. Herrin, Z. Haydar, and D. J. Ballard
Quality of Care of Medicare Patients With Diabetes in a Metropolitan Fee-for-Service Primary Care Integrated Delivery System
American Journal of Medical Quality, November 1, 2005; 20(6): 344 - 352.
[Abstract] [PDF]

Home page
 The Annals of PharmacotherapyHome page
P. J Kiel and A. D McCord
Pharmacist Impact on Clinical Outcomes in a Diabetes Disease Management Program via Collaborative Practice
Ann. Pharmacother., November 1, 2005; 39(11): 1828 - 1832.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
A. J Palmer, D. M D Tucker, J. A Ray, W. J Valentine, C. Currie, P. McEwan, and M. Brandle
Insulin pumps: more consultation was needed
BMJ, October 15, 2005; 331(7521): 905 - 906.
[Full Text]

Home page
 The Diabetes EducatorHome page
D. C. Ziemer, C. D. Miller, M. K. Rhee, J. P. Doyle, C. Watkins Jr, C. B. Cook, D. L. Gallina, I. M. El-Kebbi, C. S. Barnes, V. G. Dunbar, et al.
Clinical Inertia Contributes to Poor Diabetes Control in a Primary Care Setting
The Diabetes Educator, July 1, 2005; 31(4): 564 - 571.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
M. W. Strum, R. Hopkins, D. S. West, and B. N. Harris
Effects of a medication assistance program on health outcomes in patients with type 2 diabetes mellitus
Am. J. Health Syst. Pharm., May 15, 2005; 62(10): 1048 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
E. M. Ozanne and L. J. Esserman
Evaluation of Breast Cancer Risk Assessment Techniques: A Cost-effectiveness Analysis
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2043 - 2052.
[Abstract] [Full Text] [PDF]

Home page
 Ann Fam MedHome page
A. G. Mainous III, D. E. King, D. R. Garr, and W. S. Pearson
Race, Rural Residence, and Control of Diabetes and Hypertension
Ann. Fam. Med, November 1, 2004; 2(6): 563 - 568.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
American Diabetes Association Consensus Panel
Guidelines for Computer Modeling of Diabetes and Its Complications
Diabetes Care, September 1, 2004; 27(9): 2262 - 2265.
[Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
P. Zhang, M. M. Engelgau, S. L. Norris, E. W. Gregg, and K. M. Venkat Narayan
Application of Economic Analysis to Diabetes and Diabetes Care
Ann Intern Med, June 1, 2004; 140(11): 972 - 977.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
S. Rowe, C. H. MacLean, and P. G. Shekelle
Preventing Visual Loss From Chronic Eye Disease in Primary Care: Scientific Review
JAMA, March 24, 2004; 291(12): 1487 - 1495.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. M. Eddy and L. Schlessinger
Archimedes: A trial-validated model of diabetes
Diabetes Care, November 1, 2003; 26(11): 3093 - 3101.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Kahn
Dealing With Complexity in Clinical Diabetes: The value of Archimedes
Diabetes Care, November 1, 2003; 26(11): 3168 - 3171.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
Z. T. Bloomgarden
Prevention of Obesity and Diabetes
Diabetes Care, November 1, 2003; 26(11): 3172 - 3178.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
W. H. Herman
Diabetes Modeling
Diabetes Care, November 1, 2003; 26(11): 3182 - 3183.
[Full Text] [PDF]

Home page
 PediatricsHome page
B. M. Svoren, D. Butler, B.-S. Levine, B. J. Anderson, and L. M. B. Laffel
Reducing Acute Adverse Outcomes in Youths With Type 1 Diabetes: A Randomized, Controlled Trial
Pediatrics, October 1, 2003; 112(4): 914 - 922.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Brandle, H. Zhou, B. R.K. Smith, D. Marriott, R. Burke, B. P. Tabaei, M. B. Brown, and W. H. Herman
The Direct Medical Cost of Type 2 Diabetes
Diabetes Care, August 1, 2003; 26(8): 2300 - 2304.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. E. Molitch, W. Fujimoto, R. F. Hamman, and W. C. Knowler
The Diabetes Prevention Program and Its Global Implications
J. Am. Soc. Nephrol., July 1, 2003; 14(90002): S103 - 107.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
A. Bagust and S. Beale
Deteriorating beta-cell function in type 2 diabetes: a long-term model
QJM, April 1, 2003; 96(4): 281 - 288.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
S. Vijan and R. A. Hayward
Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care
Ann Intern Med, April 1, 2003; 138(7): 593 - 602.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
D. R. Arday, B. B. Fleming, D. K. Keller, P. W. Pendergrass, R. J. Vaughn, J. M. Turpin, and D. A. Nicewander
Variation in Diabetes Care Among States: Do patient characteristics matter?
Diabetes Care, December 1, 2002; 25(12): 2230 - 2237.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. T. Coffey, M. Brandle, H. Zhou, D. Marriott, R. Burke, B. P. Tabaei, M. M. Engelgau, R. M. Kaplan, and W. H. Herman
Valuing Health-Related Quality of Life in Diabetes
Diabetes Care, December 1, 2002; 25(12): 2238 - 2243.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. R. Sowers and S. Haffner
Treatment of Cardiovascular and Renal Risk Factors in the Diabetic Hypertensive
Hypertension, December 1, 2002; 40(6): 781 - 788.
[Full Text] [PDF]

Home page
 Med Decis MakingHome page
S. R. Earnshaw, A. Richter, S. W. Sorensen, T. J. Hoerger, K. A. Hicks, M. Engelgau, T. Thompson, K. M. V. Narayan, D. F. Williamson, E. Gregg, et al.
Optimal Allocation of Resources Across Four Interventions for Type 2 Diabetes
Med Decis Making, October 1, 2002; 22(5_suppl): S80 - S91.
[Abstract] [PDF]

Home page
 Diabetes CareHome page
K. G. Dawson, D. Gomes, H. Gerstein, J. F. Blanchard, and K. H. Kahler
The Economic Cost of Diabetes in Canada, 1998
Diabetes Care, August 1, 2002; 25(8): 1303 - 1307.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
V. Kothari, R. J. Stevens, A. I. Adler, I. M. Stratton, S. E. Manley, H. A. Neil, and R. R. Holman
UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine
Stroke, July 1, 2002; 33(7): 1776 - 1781.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
The CDC Diabetes Cost-effectiveness Group
Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes
JAMA, May 15, 2002; 287(19): 2542 - 2551.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. Sidorov, R. Shull, J. Tomcavage, S. Girolami, N. Lawton, and R. Harris
Does Diabetes Disease Management Save Money and Improve Outcomes? : A report of simultaneous short-term savings and quality improvement associated with a health maintenance organization-sponsored disease management program among patients fulfilling health employer data and information set criteria
Diabetes Care, April 1, 2002; 25(4): 684 - 689.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
J. J. Caro, A. J. Ward, and J. A. O'Brien
Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S.
Diabetes Care, March 1, 2002; 25(3): 476 - 481.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Lamotte, L. Annemans, A. Lefever, M. Nechelput, and J. Masure
A Health Economic Model to Assess the Long-Term Effects and Cost-Effectiveness of Orlistat in Obese Type 2 Diabetic Patients
Diabetes Care, February 1, 2002; 25(2): 303 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
B. B. Fleming, S. Greenfield, M. M. Engelgau, L. M. Pogach, S. B. Clauser, and M. A. Parrott
The Diabetes Quality Improvement Project: Moving science into health policy to gain an edge on the diabetes epidemic
Diabetes Care, October 1, 2001; 24(10): 1815 - 1820.
[Full Text] [PDF]

Home page
 JAMAHome page
E. H. Wagner, N. Sandhu, K. M. Newton, D. K. McCulloch, S. D. Ramsey, and L. C. Grothaus
Effect of Improved Glycemic Control on Health Care Costs and Utilization
JAMA, January 10, 2001; 285(2): 182 - 189.
[Abstract] [Full Text] [PDF]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
G. S. Meneilly and D. Tessier
Diabetes in Elderly Adults
J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2001; 56(1): 5M - 13.
[Abstract] [Full Text]

Home page
 Diabetes CareHome page
S. A. Grover, L. Coupal, H. Zowall, C. M. Alexander, T. W. Weiss, and D. R.J. Gomes
How Cost-Effective Is the Treatment of Dyslipidemia in Patients With Diabetes but Without Cardiovascular Disease?
Diabetes Care, January 1, 2001; 24(1): 45 - 50.
[Abstract] [Full Text]

Home page
 Diabetes CareHome page
J. Menzin, C. Langley-Hawthorne, M. Friedman, L. Boulanger, and R. Cavanaugh
Potential Short-Term Economic Benefits of Improved Glycemic Control: A managed care perspective
Diabetes Care, January 1, 2001; 24(1): 51 - 55.
[Abstract] [Full Text]

Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
M. H. Chin, A. W. Su, L. Jin, and M. P. Nerney
Variations in the Care of Elderly Persons With Diabetes Among Endocrinologists, General Internists, and Geriatricians
J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2000; 55(10): 601M - 606.
[Abstract] [Full Text]

Home page
 CirculationHome page
S. A. Grover, L. Coupal, H. Zowall, and M. Dorais
Cost-Effectiveness of Treating Hyperlipidemia in the Presence of Diabetes : Who Should Be Treated?
Circulation, August 15, 2000; 102(7): 722 - 727.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. C. Javitt, G. C. Brown, M. M. Brown, S. Sharma, H. D. Hoskins, Jr, S. Vijan, T. P. Hofer, and R. A. Hayward
How Often Should Patients With Diabetes Be Screened for Retinopathy?
JAMA, July 26, 2000; 284(4): 437 - 439.
[Full Text] [PDF]

Home page
 JAMAHome page
C. M. Clark, J. E. Fradkin, R. G. Hiss, R. A. Lorenz, F. Vinicor, and E. Warren-Boulton
Promoting Early Diagnosis and Treatment of Type 2 Diabetes: The National Diabetes Education Program
JAMA, July 19, 2000; 284(3): 363 - 365.
[Full Text] [PDF]

Home page
 BMJHome page
A. Gray, M. Raikou, A. McGuire, P. Fenn, R. Stevens, C. Cull, I. Stratton, A. Adler, R. Holman, and R. Turner
Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)
BMJ, May 20, 2000; 320(7246): 1373 - 1378.
[Abstract] [Full Text]

Home page
 CMAJHome page
J. Mahon
Direct and indirect randomized trials of screening: the A's and D's of evidence-based clinical practice guidelines
Can. Med. Assoc. J., April 1, 2000; 162(7): 1002 - 1004.
[Full Text] [PDF]

Home page
 JAMAHome page
S. Vijan, T. P. Hofer, and R. A. Hayward
Cost-Utility Analysis of Screening Intervals for Diabetic Retinopathy in Patients With Type 2 Diabetes Mellitus
JAMA, February 16, 2000; 283(7): 889 - 896.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. J. Neumann, R. C. Hermann, K. M. Kuntz, S. S. Araki, S. B. Duff, J. Leon, P. A. Berenbaum, P. A. Goldman, L. W. Williams, and M. C. Weinstein
Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease
Neurology, April 1, 1999; 52(6): 1138 - 1138.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
E. Goyder and L. Irwig
Screening for diabetes: what are we really doing?
BMJ, December 12, 1998; 317(7173): 1644 - 1646.
[Full Text]

Home page
 JAMAHome page
The CDC Diabetes Cost-Effectiveness Study Group
The Cost-effectiveness of Screening for Type 2 Diabetes
JAMA, November 25, 1998; 280(20): 1757 - 1763.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. A. Testa and D. C. Simonson
Health Economic Benefits and Quality of Life During Improved Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Randomized, Controlled, Double-Blind Trial
JAMA, November 4, 1998; 280(17): 1490 - 1496.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
UK Prospective Diabetes Study Group
Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
BMJ, September 12, 1998; 317(7160): 720 - 726.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. J. Rubin, K. A. Dietrich, and A. D. Hawk
Clinical and Economic Impact of Implementing a Comprehensive Diabetes Management Program in Managed Care
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2635 - 2642.
[Abstract] [Full Text]

Home page
 Arch Intern MedHome page
K. H. Bachman and S. Dagogo-Jack
Cost of Troglitazone Therapy
Arch Intern Med, May 11, 1998; 158(9): 1038 - 1038.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.